Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search

Search

  1. Home
  2. Homepage
Filter by
  • Filter by
  • Remove this filter Public health area: Public health threat
  • Remove this filter Public health area: Antimicrobial resistance
  • Infectious disease
    • Healthcare-associated infections (14)
    • Nosocomial infections (10)
    • Vaccine preventable diseases (9)
    • Respiratory diseases (8)
    • Food- and waterborne diseases (7)
    • Zoonosis (7)
    • Sexually transmitted infections (7)
    • Tuberculosis (5)
    • Influenza (5)
    • Carbapenem-resistant Enterobactericae (5)
    • Viral haemorrhagic fever (4)
    • Gonorrhoea (4)
    • Poliomyelitis (3)
    • Ebola haemorrhagic fever (3)
    • Middle East respiratory syndrome coronavirus (3)
    • Mycobacterium chimaera (3)
    • Coronavirus (3)
    • Klebsiella pneumoniae (3)
    • S. pneumoniae (2)
    • Streptococcus pneumoniae (2)
    • Invasive pneumococcal disease (2)
    • Acquired immunodeficiency syndrome (AIDS) (2)
    • Human immunodeficiency virus infection (2)
    • Enterohaemorrhagic Escherichia coli (EHEC) infection (2)
    • Multidrug-resistant tuberculosis (2)
    • HIV infection (2)
    • Vector-borne disease (2)
    • Escherichia coli infection (2)
    • Viral hepatitis (2)
    • Salmonellosis (2)
    • Pneumococcal disease (2)
    • Emerging disease (1)
    • Flu (1)
    • Seasonal influenza (1)
    • Hepatitis (1)
    • Methicillin-resistant Staphylococcus aureus (MRSA) (1)
    • Clostridium difficile infection (1)
    • Crimean-Congo haemorrhagic fever (1)
    • Zika virus disease (1)
    • Travel related infections (1)
    • Chikungunya virus disease (1)
    • Influenza in humans, seasonal (1)
    • Chlamydia infection (1)
    • Hepatitis A (1)
    • West Nile virus infection (1)
    • Mosquito-borne diseases (1)
    • Syphilis (1)
    • Tick-borne diseases (1)
    • Legionnaires’ disease (1)
    • Anthrax (1)
    • Candida auris (1)
  • Public health area
    • Public health threat (33)
    • Antimicrobial resistance (33)
    • Outbreak (33)
    • Antibiotic resistance (33)
    • Threats and outbreaks (33)
    • Scientific advice (13)
    • Surveillance (6)
    • Microbiology (5)
    • Epidemic (2)
    • Preparedness (2)
    • Multidrug resistance (2)
    • Transmission of disease (1)
    • Epidemic intelligence (1)
    • Prevention and control (1)
    • Training (1)
    • Mass gathering (1)
    • Laboratories (1)
    • Country cooperation (1)
    • Disease prevention (1)
    • Prophylaxis (1)
    • Laboratory capacity (1)
    • Whole genome sequencing (1)
  • Country
    • Europe (22)
    • Africa (3)
    • North America (2)
    • Asia (1)
    • Americas (1)
  • Type
    • Publication (27)
    • Risk assessment (15)
    • Peer-reviewed publication (8)
    • Surveillance report (3)
    • News (3)
    • ECDC comment (3)
    • Event (2)
    • Technical report (1)
    • Data (1)
    • Platform (1)
  • Page 1 of 4 // 33 Results found
    • Sort by:

Publication

Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities, with special emphasis on cross-border transfer

Risk assessment - 13 Sep 2011

The purpose of this risk assessment is to evaluate the risk to the citizens of Europe of CPE spread through patient mobility and to assess the effectiveness of infection control methods to stop the spread of CPE within healthcare institutions.

110913_Risk_assessment_resistant_CPE.pdf - EN - [PDF-801.15 KB]
  • Antimicrobial resistance
  • Europe
  • Healthcare-associated infections
  • Public health threat
  • Scientific advice

Publication

Updated ECDC risk assessment on the spread of New Delhi metallo-β-lactamase (NDM) and its variants within Europe

Risk assessment - 17 Nov 2011
1111_TER_Risk-assessment-NDM.pdf - EN - [PDF-744.92 KB]
  • Antimicrobial resistance
  • Antimicrobial Resistance and Healthcare-associated Infections Programme
  • Europe
  • Public health threat
  • Scientific advice

Publication

Rapid risk assessment: Potential contamination of Viaspan® organ perfusion solution

Risk assessment - 23 Apr 2012
1204-TER-Risk-assessment-contamination-perfusion-solution.pdf - EN - [PDF-660.77 KB]
  • Antimicrobial resistance
  • Antimicrobial Resistance and Healthcare-associated Infections Programme
  • Europe
  • Microbiology
  • Public health threat
  • Scientific advice

Publication

Invasive cardiovascular infection by Mycobacterium chimaera potentially associated with heater-cooler units used during cardiac surgery, 30 April 2015

Risk assessment - 30 Apr 2015

​Since 2011, cases of infection caused by Mycobacterium chimaera have been detected in patients having previously undergone cardiac surgery in Europe.

Invasive cardiovascular infection by Mycobacterium chimaera potentially associated with heater-cooler units used during cardiac surgery - EN - [PDF-388.49 KB]
  • Antimicrobial resistance
  • Healthcare-associated infections
  • Mycobacterium chimaera
  • Public health threat
  • Scientific advice

Publication

Communicable disease threats report, Week 20, 10-16 May 2015

Surveillance report - 15 May 2015

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 May 2015, and includes updates on influenza, Salmonella Enteritidis, polio, avian influenza, Ebola virus, Mycobacterium chimaera and MERS.

Communicable Disease Threats Report, 16 May 2015 - EN - [PDF-5.14 MB]
  • Antimicrobial resistance
  • Antimicrobial Resistance and Healthcare-associated Infections Programme
  • Ebola haemorrhagic fever
  • Emerging and Vector-borne Diseases Programme
  • Europe
  • Healthcare-associated infections
  • Influenza
  • Influenza in humans, seasonal
  • Latvia
  • Middle East respiratory syndrome coronavirus
  • Mycobacterium chimaera
  • Poliomyelitis
  • Public health threat
  • Salmonellosis
  • Vaccine Preventable Diseases Programme
  • Western Africa

Publication

Communicable disease threats report, 17-23 May 2015, week 21

Surveillance report - 22 May 2015

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 17-23 May 2015, and includes updates on Salmonella Enteritidis, influenza, Mycobacterium chimaera, Ebola virus, MERS, avian influenza and polio.

Communicable Disease Threats Report, 23 May 2015 - EN - [PDF-4.32 MB]
  • Antimicrobial resistance
  • Ebola haemorrhagic fever
  • Europe
  • Healthcare-associated infections
  • Influenza
  • Latvia
  • Middle East respiratory syndrome coronavirus
  • Mycobacterium chimaera
  • Poliomyelitis
  • Public health threat
  • Salmonellosis
  • Western Africa

Publication

Communicable disease threats report, 15-21 November 2015, week 47

Surveillance report - 20 Nov 2015

​This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 15-21 November 2015 and includes updates on Zika virus, MERS and Ebola virus disease.

Communicable Disease Threats Report, 21 November 2015 - EN - [PDF-2.71 MB]
  • Antimicrobial resistance
  • Brazil
  • Chikungunya virus disease
  • China
  • Ebola haemorrhagic fever
  • Europe
  • Influenza
  • Middle East respiratory syndrome coronavirus
  • Poliomyelitis
  • Public health threat
  • West Nile virus infection
  • Western Africa
  • Zika virus disease

Publication

Rapid risk assessment: Carbapenem-resistant Enterobacteriaceae, 14 April 2016

Risk assessment - 14 Apr 2016

This rapid risk assessment provides several options to reduce the risk of CRE, e.g. treatment options, transmission prevention and measures related to the healthcare system.

RRA: Carbapenem-resistant Enterobacteriaceae - EN - [PDF-1.16 MB]
  • Antimicrobial resistance
  • Carbapenem-resistant Enterobactericae
  • Healthcare-associated infections
  • Public health threat
  • Scientific advice

Publication

Rapid Risk Assessment: Plasmid-mediated colistin resistance in Enterobacteriaceae, 15 June 2016

Risk assessment - 15 Jun 2016

This document assesses the risk for patients and healthcare systems in the EU/EEA due to the global mcr-1 plasmid-mediated gene epidemic.

RRA: Plasmid-mediated colistin resistance in Enterobacteriaceae - EN - [PDF-602.67 KB]
  • Antimicrobial resistance
  • Carbapenem-resistant Enterobactericae
  • Europe
  • Public health threat
  • Scientific advice

Publication

Rapid risk assessment: Carbapenem-resistant Acinetobacter baumannii in healthcare settings – 8 December 2016

Risk assessment - 9 Dec 2016

This risk assessment provides an overview of the epidemiological situation in Europe and describes a number of response options.

RRA: Carbapenem-resistant Acinetobacter baumannii in healthcare settings, 8 December 2016 - EN - [PDF-657.76 KB]
  • Antimicrobial resistance
  • Europe
  • Healthcare-associated infections
  • Public health threat
  • Scientific advice

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Next page ››
  • Last page Last »
  • About us

    • What we do
    • Who we are
    • Governance
    • Partnerships and networks
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2019
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us